Article Information
History
- November 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Simon P. Fraessle1,#,
- Claudia Tschulik1,#,
- Manuel Effenberger1,#,*,
- Vlad Cletiu1,
- Maria Gerget1,
- Kilian Schober2,
- Dirk H. Busch2,
- Lothar Germeroth1,
- Christian Stemberger1 and
- Mateusz P. Poltorak1
- 1Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675 Munich, Germany
- 2Institute for Medical Microbiology Immunology and Hygiene, Technical University of Munich, Munich, Germany
- ↵*corresponding author Materials & Correspondence
Correspondence and material requests should be addressed to Dr. Manuel Effenberger (manuel.effenberger{at}bms.com).
Posted November 08, 2022.
Activation-inducible CAR expression enables precise control over engineered CAR T cell function
